Risk Factors for the Non-timely Diagnosis of Pediatric Type 1 Diabetes
Journal of the Endocrine Society · 2026-11-10
DOI: 10.1210/jendso/bvag261 ↗Abstract
Abstract Purpose Non-timely Diagnosis of type 1 diabetes is associated with complications, hinders the therapeutic relationship, and compromises diabetes care delivery. This study aims to identify sociodemographic and clinical risk factors for Non-timely Diagnosis of pediatric type 1 diabetes. Methods We identified youth (6m–21yrs) diagnosed with type 1 diabetes (ADA definition and 1+autoantibody) at Stanford Children’s Hospital from 01/2021-11/2023. Through ICD-10 code review in the STAnford Research Repository followed by chart review of all clinical data, two-person coding team determined if type 1 diabetes was diagnosed Timely or Non-timely. Non-timely was categorized as Unrecognized (symptoms attributed to another diagnosis) or Misclassified (type 2 diabetes diagnosis). Analysis via multivariate logistic regression identified sociodemographic and clinical risk factors for Non-timely Diagnosis. Results Of 197 youth with type 1 diabetes, 49 (25%) were Non-timely Diagnosed (7% Unrecognized, 18% Misclassified). A majority of those who were Unrecognized (78%) and Misclassified (77%) were seen initially in the primary care setting. Acanthosis (aOR=11.25 [3.18,39.80]) was a risk factor for Non-timely Diagnosis, while hospitalization (aOR=0.25 [0.10,0.61]), and female sex (aOR=0.24 [0.09,0.66]) were protective associations. Conclusions A quarter of youth in our study did not receive a timely diagnosis of type 1 diabetes. This study highlights the need for timely and accurate type 1 diabetes diagnosis to reduce delays, establish strong therapeutic relationships, and ensure access to disease modifying immunotherapy. Interventions to combat Non-timely Diagnosis should focus on primary care and diabetes clinic settings. With over 1 in 6 youth Misclassified, autoantibodies are critical to improving diagnostic clarity.
EUVIMED